1. Home
  2. DEVS vs SPRB Comparison

DEVS vs SPRB Comparison

Compare DEVS & SPRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DEVS
  • SPRB
  • Stock Information
  • Founded
  • DEVS N/A
  • SPRB 2014
  • Country
  • DEVS Canada
  • SPRB United States
  • Employees
  • DEVS N/A
  • SPRB N/A
  • Industry
  • DEVS
  • SPRB Medicinal Chemicals and Botanical Products
  • Sector
  • DEVS
  • SPRB Health Care
  • Exchange
  • DEVS NYSE
  • SPRB Nasdaq
  • Market Cap
  • DEVS 16.5M
  • SPRB 15.7M
  • IPO Year
  • DEVS N/A
  • SPRB 2020
  • Fundamental
  • Price
  • DEVS $0.78
  • SPRB $0.40
  • Analyst Decision
  • DEVS
  • SPRB Hold
  • Analyst Count
  • DEVS 0
  • SPRB 7
  • Target Price
  • DEVS N/A
  • SPRB $2.17
  • AVG Volume (30 Days)
  • DEVS 9.6M
  • SPRB 885.3K
  • Earning Date
  • DEVS 02-12-2025
  • SPRB 11-11-2024
  • Dividend Yield
  • DEVS N/A
  • SPRB N/A
  • EPS Growth
  • DEVS N/A
  • SPRB N/A
  • EPS
  • DEVS N/A
  • SPRB N/A
  • Revenue
  • DEVS N/A
  • SPRB $7,101,000.00
  • Revenue This Year
  • DEVS N/A
  • SPRB N/A
  • Revenue Next Year
  • DEVS N/A
  • SPRB N/A
  • P/E Ratio
  • DEVS N/A
  • SPRB N/A
  • Revenue Growth
  • DEVS N/A
  • SPRB N/A
  • 52 Week Low
  • DEVS $0.48
  • SPRB $0.37
  • 52 Week High
  • DEVS $1.91
  • SPRB $5.95
  • Technical
  • Relative Strength Index (RSI)
  • DEVS N/A
  • SPRB 36.54
  • Support Level
  • DEVS N/A
  • SPRB $0.37
  • Resistance Level
  • DEVS N/A
  • SPRB $0.42
  • Average True Range (ATR)
  • DEVS 0.00
  • SPRB 0.04
  • MACD
  • DEVS 0.00
  • SPRB -0.01
  • Stochastic Oscillator
  • DEVS 0.00
  • SPRB 15.31

About DEVS DEVVSTREAM CORP

DevvStream Corp is a technology based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve their sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.

About SPRB Spruce Biosciences Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

Share on Social Networks: